THC Biomed Intl Ltd.

$0.00 0.00%(+$0.00)
TickerSpark Score
47/100
Weak
80
Valuation
20
Profitability
55
Growth
52
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THCBF research report →

52-Week Range0% of range
Low
$0.00
Current
$0.00
High
$0.02
Company Overviewthcbiomed.com

About the company

THC Biomed Intl Ltd. is a Canadian enterprise engaged in the production and sale of cannabis products for both medical and recreational consumers. Its offerings encompass a range of cannabis-infused edibles and drinks, such as beverage shots, gummies, and biscuits marketed under the THC KISS label, in addition to standalone pure cannabis sticks.

CEO
John Miller
IPO
2018
Employees
35
HQ
Kelowna, BC, CA

Price Chart

+0.00% · this period
$0.00$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$205.01K
P/E
-1.07
P/S
0.98
P/B
0.47
EV/EBITDA
-4.45
Div Yield
0.00%
Profitability
Gross Margin
-30.83%
Op Margin
-95.89%
Net Margin
-91.79%
ROE
-36.68%
ROIC
-28.04%
Growth & Income
Revenue
$2.45M · -35.10%
Net Income
$-3,065,848 · 51.79%
EPS
$-0.02 · 51.93%
Op Income
$-2,709,735
FCF YoY
-43.76%
Performance & Tape
52W High
$0.02
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-0.36
Avg Volume
1.23K

Get TickerSpark's AI analysis on THCBF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · THCBF

Our THCBF coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on THCBF yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate THCBF report →
Internal Compare

Similar companies

Peers in the same neighborhood.